Cargando…
LB11. Rapid Rise in Decreased Susceptibility to Azithromycin among Shigella Isolates in the United States: A Look at National Surveillance Data, 2011–2017
BACKGROUND: Shigella spp. cause ~500,000 illnesses in the United States annually. Antibiotics are recommended for immunocompromised patients and shorten the duration of illness, thus limiting spread. First-line treatments include ciprofloxacin (CIP) and azithromycin (AZM). CIP resistance is a growin...
Autores principales: | Friedman, Cindy, Plumb, Ian, Reynolds, Jared, Chen, Jessica, Tagg, Kaitlin, Caidi, Hayat, Watkins, Louise Francois, Karp, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253243/ http://dx.doi.org/10.1093/ofid/ofy229.2185 |
Ejemplares similares
-
130. increase in Multidrug Resistance (2011–2018) and the Emergence of Extensive Drug Resistance (2020) in shigella Sonnei in the United States
por: Logan, Naeemah Z, et al.
Publicado: (2020) -
81. Azithromycin-Nonsusceptible Salmonella Newport Infections Associated with Mexican-style Soft Cheese and Beef—the United States, 2018–2019
por: Plumb, Ian D, et al.
Publicado: (2019) -
Multidrug-Resistant Salmonella Serotype Anatum in Travelers and Seafood from Asia, United States
por: Karp, Beth E., et al.
Publicado: (2020) -
1603. Observation of Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community—Vermont, 2018
por: Gharpure, Radhika, et al.
Publicado: (2019) -
Azithromycin Resistance in Shigella spp. in Southeast Asia
por: Darton, Thomas C., et al.
Publicado: (2018)